Ionis Pharmaceuticals's market cap is currently $5.04B. The company's EPS TTM is $-3.038; its P/E ratio is ―; Ionis Pharmaceuticals is scheduled to report earnings on February 19, 2025, and the estimated EPS forecast is $-1.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 787.65M	$ 587.00M	$ 810.00M	$ 729.00M	$ 1.12B
Gross Profit	$ 778.51M	$ 573.00M	$ 799.00M	$ 717.00M	$ 1.12B
Operating Income	$ -353.73M	$ -411.00M	$ -30.00M	$ -172.00M	$ 366.00M
EBITDA	$ -230.01M	$ -227.76M	$ -239.00K	$ -107.88M	$ 411.53M
Net Income	$ -366.29M	$ -270.00M	$ -29.00M	$ -487.00M	$ 294.00M
Balance Sheet
Cash & Short-Term Investments	$ 2.33B	$ 1.99B	$ 2.12B	$ 1.89B	$ 2.50B
Total Assets	$ 2.99B	$ 2.53B	$ 2.61B	$ 2.39B	$ 3.23B
Total Debt	$ 1.45B	$ 1.34B	$ 1.16B	$ 749.00M	$ 710.00M
Net Debt	$ 1.05B	$ -642.00M	$ -954.00M	$ -1.14B	$ -1.79B
Total Liabilities	$ 2.60B	$ 1.96B	$ 1.84B	$ 1.55B	$ 1.55B
Stockholders' Equity	$ 386.69M	$ 573.00M	$ 772.00M	$ 843.00M	$ 1.47B
Cash Flow
Free Cash Flow	$ -335.52M	$ -294.47M	$ 12.90M	$ -5.16M	$ 309.44M
Operating Cash Flow	$ -307.51M	$ -274.37M	$ 30.80M	$ 35.89M	$ 345.72M
Investing Cash Flow	$ -214.13M	$ -262.64M	$ 194.91M	$ 274.48M	$ -41.27M
Financing Cash Flow	$ 644.08M	$ -55.30M	$ 245.93M	$ -596.61M	$ 100.02M

Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

Income Statement >

Ionis Pharmaceuticals Debt to Assets

Balance Sheet >

Ionis Pharmaceuticals Cash Flow

Cash Flow >

Ionis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing